Abstract
The regulatory subunits of cell cycle-regulated kinases, cyclins, are key regulators of cell cycle progression in eukaryotic cells. Mammalian cells contain at least five cyclin classes (cyclins A to E), which reach maximum abundance at different points in the cell cycle1. The transcriptional activation of cyclin genes and consequent transient accumulation of different cyclin proteins which then bind to one of the cyclin-dependent kinases (cdks) to initiate phosphorylation cascades is thought to be the central mechanism for a series of control points in the mammalian cell cycle1–3. in synchronised or growth factor-stimulated mammalian cells, cyclins C, D1, D2, D3 and E are most abundant during G1 phase4–8, suggesting that these cyclins may function at G1 control points. This is supported by recent evidence that cyclin E is rate-limiting for progression through G1 9 and that complex formation between D type cyclins and the cdk4 kinase is maximum in late G1 phase10.
This is a preview of subscription content, log in via an institution.
Buying options
Tax calculation will be finalised at checkout
Purchases are for personal use only
Learn about institutional subscriptionsPreview
Unable to display preview. Download preview PDF.
References
T. Hunter, and J. Pines, Cyclins and cancer, Cell 66: 1071 (1991).
S.I. Reed, The role of p34 kinases in the G1 to S-phase transition, Annu. Rev. Cell Biol. 8: 529 (1992).
P. Nurse, Universal control mechanism regulating onset of M-phase, Nature 344: 503 (1990).
H. Matsushime, M.F. Roussel, R.A. Ashmun, and C.J. Sherr, Colony-stimulating factor 1 regulates novel cyclfns during the G1 phase of the cell cycle, Cell 65: 701 (1991).
T. Motokura, T. Bloom, H.G. Kim, H. Jüppner, J. Ruderman, H. Kronenberg, and A. Arnold, A novel cyclin encoded by a bcll-linked candidate oncogene, Nature 350: 512 (1991).
T. Motokura, K. Keyomarsi, H.M. Kronenberg, and A. Arnold, Cloning and characterization of human cyclin D3, a cDNA closely related in sequence to the PRAD1/cyclin D1 proto-oncogene, J. Biol. Chem. 267: 20412 (1992).
D.J. Lew, V. Dulic, and S.I. Reed, Isolation of three novel human cyclfns by rescue of G1 cyclin (Cln) function in yeast, Cell 66: 1197 (1991).
K.-A. Won, Y. Xiong, D. Beach, and M.Z. Gilman, Growth regulated expression of D-type cyclin genes in human diploid fibroblasts, Proc. Natl. Acad. Sci. USA 89: 9910 (1992).
M. Ohtsubo, and J.M. Roberts, Cyclin-dependent regulation of G1 in mammalian fibroblasts, Science 259: 1908 (1993).
H. Matsushime, M.E. Ewen, D.K. Strom, J.-Y. Kato, S.K. Hanks M.F. Roussel, and C.J. Sherr, Identification and properties of an atypical catalytic subunit (p34PSK-J3/cdk4) for mammalian D type G1 cyclfns, Cell 71: 323 (1992).
R.L. Sutherland, R.R. Reddel, and M.D. Green, Effects of oestrogens on cell proliferation and cell cycle kinetics. A hypothesis on the cell cycle effects of antoestrogens, Eur. J. Cancer Clin. Oncol. 19: 307 (1983).
E.A. Musgrove, and R.L. Sutherland, Steroids, growth factors and cell cycle controls in breast cancer, in: “Regulatory Mechanisms in Breast Cancer”. M.E. Lippman, and R.B. Dickson, eds, Kluwer Academic Publishers, Boston (1991)
E.A. Musgrove, C.S.L. Lee, and R.L. Sutherland, Progestins both stimulate and inhibit breast cancer cell cycle progression while increasing expression of transforming growth factor a, epidermal growth factor receptor, c fos and c-myc genes, Mol. Cell. Biol. 11: 5032 (1991).
M. Beato, Gene regulation by steroid hormones, Cell 56: 335 (1989).
S.E. Fawell, J.A. Lees, R. White, and M.G. Parker, Characterization and colocalization of steroid binding and dimerization activities in the mouse estrogen receptor, Cell 60: 953 (1990).
N.J.G. Webster, S. Green, J.R. Jin, and P. Chambon, The hormone-binding domains of the estrogen and glucocorticoid receptors contain an inducible transcription activation function, Cell 54: 199 (1988).
P. Gaudray, P. Szepetowskf, C. Escot, D. Birnbaum, and C. Theillet, DNA amplification at 11g13 in human cancer: from complexity to perplexity, Mutation Res. 276: 317 (1992).
C.L. Rosenberg, E. Wong, E.M. Petty, A.E. Bale, Y. Tsujimoto, N.L. Harris, and A. Arnold, PRADl, a candidate BCL1 oncogene: mapping and expression in centrocytic lymphoma, Proc. Natl. Acad. Sci. USA. 88: 9638 (1991).
D.A. Withers, R.C. Harvey, J.B. Faust, O. Melnyk, K. Carey, and T.C. Meeker, Characterization of a candidate bel-1 gene, Mol. Cell. Biol. 11: 4846 (1991).
D.A. Withers, R.C. Harvey, J.B. Faust, O. Melnyk, K. Carey, and T.C. Meeker, Characterization of a candidate bel-1 gene, Mol. Cell. Biol. 11: 4846 (1991).
P. Gallant, and E.A. Nigg, Cyclin B2 undergoes cell cycle-dependent nuclear translocation and, when expressed as a non-destructible mutant, causes mitotic arrest in HeLa cells, J. Cell Biol. 117: 213 (1992).
E.A. Musgrove, J.A. Hamilton, C.S.L. Lee, K.J.E. Sweeney, C.K.W. Watts, and R.L. Sutherland, Growth factor, steroid and steroid antagonist regulation of cyclin gene expression associated with changes in T-47D human breast cancer cell cycle progression, Mol. Cell. Biol. 13: 3577 (1993).
E.A. Musgrove, J.A. Hamilton, C.S.L. Lee, K.J.E. Sweeney, C.K.W. Watts, and R.L. Sutherland, Growth factor, steroid and steroid antagonist regulation of cyclin gene expression associated with changes in T-47D human breast cancer cell cycle progression, Mol. Cell. Biol. 13: 3577 (1993).
I.W. Taylor, P.J. Hodson, M.D. Green, and R.L. Sutherland, Effects of tamoxifen on cell cycle progression of synchronous MCF-7 human mammary carcinoma cells, Cancer Res. 43: 4007 (1983).
E.A. Musgrove, A.E. Wakeling, and R.L. Sutherland, Points of action of estrogen antagonists and a calmodulin antagonist within the MCF-7 human breast cancer cell cycle, Cancer Res. 49: 2398 (1989).
E.A. Musgrove, and R.L. Sutherland, Effects of the progestin antagonist RU 486 on T-47D cell proliferation, submitted.
A.E. Wakeling, and J. Bowler, Steroidal pure antioestrogens, J. Endocrinol. 112: R7 (1987).
K. Keyomarsi, and A.B. Pardee, Redundant cyclin overexpression and gene amplification in breast cancer cells, Proc. Natl. Acad. Sci. USA. 90: 1112 (1993).
A. Sala, and B. Calabretta, Regulation of BALG/c 3T3 fibroblast proliferation by B-myb is accompanied by selective activation of cdc2 and cyclin D1 expresssion, Proc. Natl. Acad. Sci. USA. 89: 10415 (1992).
V. Baldin, J. Lukas, M.J. Marcote, M. Pagano, and G. Draetta, Cyclin D1 is a nuclear protein required for cell cycle progression in G1, Genes Dev. 7: 812 (1993).
E. Schuuring, E. Verhoeven, W.J. Mooi, and R.J.A.M. Michalides, Identification and cloning of two overexpressed genes, U21B31/PRAD1 and EMS1, within the amplified chromosome 11g13 region in human carcinomas, Oncogene 7: 355 (1992).
H. Tsuda, S. Hirohashi, Y. Shimosato, T. Hirota, S. Tsugane, H. Yamamoto, N. Miyajima, K. Toyoshima, T. Yamamoto, J. Yokota, T. Yoshida, H. Sakamoto, M. Terada, and T. Sugimura, Correlation between long-term survival in breast cancer patients and amplification of two putative oncogene-coamplification units: hst-l/int-2 and c-erbB2/ear-l, Cancer Res. 49: 3104 (1989).
A. Borg, H. Sigurdsson, G.M. Clark, M. Ferno, S.A. Fuqua, H. Olson, D. Kilander, and W.L. McGuire, Association of INT2/HST coamplification in primary breast cancer with hormone-dependent phenotype and poor prognosis, Br. J. Cancer. 63: 136 (1991).
E. Schuuring, E. Verhoeven, H. van Tinteren, J.L. Peterse, B. Nunnink, F.B.J.M. Thunnissen, P. Devilee, C.J. Cornelisse, M.J. van de Vijver, W.J. Mooi, and R.J.A.M. Michalides, Amplification of genes within the chromosome 11g13 region is indicative of poor prognosis in patients with operable breast cancer, Cancer Res. 52: 5229 (1992).
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1994 Springer Science+Business Media New York
About this chapter
Cite this chapter
Musgrove, E.A., Buckley, M.F., deFazio, A., Watts, C.K.W., Sutherland, R.L. (1994). Expression and Regulation of Cyclin Genes in Breast Cancer Cells. In: Hu, V.W. (eds) The Cell Cycle. GWUMC Department of Biochemistry Annual Spring Symposia. Springer, Boston, MA. https://doi.org/10.1007/978-1-4615-2421-2_38
Download citation
DOI: https://doi.org/10.1007/978-1-4615-2421-2_38
Publisher Name: Springer, Boston, MA
Print ISBN: 978-1-4613-6027-8
Online ISBN: 978-1-4615-2421-2
eBook Packages: Springer Book Archive